PMID- 35664564
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 1687-8450 (Print)
IS  - 1687-8469 (Electronic)
IS  - 1687-8450 (Linking)
VI  - 2022
DP  - 2022
TI  - The Tumor Plastic Surgery Technology versus Traditional Repair Technology on the 
      Repair of Large-Area Skin Defects after Maxillofacial Tumor Resection: A 
      Randomized Controlled Trial.
PG  - 3004695
LID - 10.1155/2022/3004695 [doi]
LID - 3004695
AB  - OBJECTIVE: To explore the effect of tumor plastic surgery on the repair of 
      large-area skin defects after maxillofacial tumor resection. METHODS: 90 patients 
      undergoing maxillofacial tumor resection in our hospital from March 2019 to March 
      2020 were selected and randomized 1 : 1 to receive either tumor plastic surgery 
      (experimental group) or traditional repair (control group). The clinical efficacy 
      and facial cosmetic improvement of the two groups were compared. The Patient and 
      Observer Scar Assessment Scale (POSAS) was used to evaluate the surgical outcomes 
      of the two groups, the Profile of Mood States (POMS) was used to evaluate the 
      patients' psychological status, and the Generic Quality of Life Inventory-74 
      (GQOLI-74) was used to assess the quality of life of patients. RESULTS: Total 
      clinical effective rate of the experimental group was significantly higher than 
      that of the control group (p < 0.001). A higher excellent rate of facial cosmetic 
      improvement was observed in the experimental group versus the control group (p < 
      0.001). Significantly lower POSAS scores of the experimental group than the 
      control group were observed (p < 0.001). The POMS scores of the experimental 
      group after treatment were lower than those of the control group (p < 0.001). 
      Tumor plastic surgery resulted in a remarkably higher GQOLI-74 score in the 
      patients versus traditional repair (p < 0.001). CONCLUSION: Tumor plastic surgery 
      is a promising alternative for patients undergoing maxillofacial tumor resection. 
      It can effectively promote the recovery of facial morphology and physiological 
      function of patients, with high clinical efficacy, so it merits promotion and 
      application.
CI  - Copyright (c) 2022 Xue-Feng Zhang et al.
FAU - Zhang, Xue-Feng
AU  - Zhang XF
AD  - Department of Orthopedics, Panzhihua Iron and Steel Group General Hospital, 
      Panzhihua, Sichuan Province, China.
FAU - Chu, Zheng
AU  - Chu Z
AUID- ORCID: 0000-0003-3275-239X
AD  - Department of Neurosurgery, Panzhihua Iron and Steel Group General Hospital, 
      Panzhihua, Sichuan Province, China.
FAU - Yang, Hong-Li
AU  - Yang HL
AD  - Department of Science and Education, General Hospital of Pangang Group, 
      Panzhihua, Sichuan Province, China.
FAU - Zhao, Bing
AU  - Zhao B
AD  - Plastic Surgery Department of Chengdu Fuli Plastic Surgery Hospital, Chengdu, 
      Sichuan Province, China.
LA  - eng
PT  - Journal Article
DEP - 20220526
PL  - Egypt
TA  - J Oncol
JT  - Journal of oncology
JID - 101496537
PMC - PMC9162858
COIS- The authors declare that they have no conflicts of interest.
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:01
PMCR- 2022/05/26
CRDT- 2022/06/06 14:16
PHST- 2021/12/31 00:00 [received]
PHST- 2022/04/12 00:00 [revised]
PHST- 2022/04/19 00:00 [accepted]
PHST- 2022/06/06 14:16 [entrez]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:01 [medline]
PHST- 2022/05/26 00:00 [pmc-release]
AID - 10.1155/2022/3004695 [doi]
PST - epublish
SO  - J Oncol. 2022 May 26;2022:3004695. doi: 10.1155/2022/3004695. eCollection 2022.